LUIS DULIN: Open Payments
NPI 1336411313 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 7 payments from 6 companies in 2025. Trend: 2023 $766 · 2024 $21 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: HETLIOZ, CAPLYTA, REXULTI, TRINTELLIX, UZEDY, COBENFY.
Industry payments across TN — which companies pay providers there.
